Targeted RNA methylation system was applied to confirm that the m6A modifications of PARP1 mRNA could play a critical role in NONO-TFE3 tRCC tumor progression. Here, PARP1 is linked to renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.